ArticleGenome medicine2026
Single-cell omics data-driven decoding of tumor clonal evolution through reinforcement learning.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTumor evolution is driven by substantial cellular heterogeneity, yet its reconstruction remains challenging with conventional bulk sequencing approaches. Single-cell transcriptomic data provide opportunities to study clonal diversity and evolutionary dynamics, but accurate inference of clonal structure and lineage relationships from these data remains difficult.
methodsWe developed single-cell reinforcement learning (RL) for evolution modeling (scRevol), an RL-based model for inferring tumor evolution from single-cell RNA sequencing (scRNA-seq) data. Using copy number variation (CNV) profiles inferred from scRNA-seq data, scRevol employs a label assignment learning strategy to generate informative embeddings, identify clonal populations, and reconstruct evolutionary trajectories. We evaluated scRevol using simulated datasets, lineage tracing data, and ovarian cancer scRNA-seq datasets.
resultsIn simulated datasets, scRevol showed robust intra-cluster coherence and accurately recovered lineage topology across varying levels of clonal complexity and noise. Compared with clustering baselines and existing methods for single-cell tumor evolution analysis, tscRevol achieved strong agreement with ground truth. In lineage tracing data, scRevol identified clonal groups associated with metastatic potential and revealed substantial metastatic heterogeneity. In ovarian cancer datasets, scRevol resolved subclonal structures across primary and metastatic lesions and associated inferred clones with distinct transcriptional and pathway-level features.
conclusionsThese results support scRevol as a practical framework for reconstructing tumor evolution from single-cell transcriptomic data and for characterizing clonal architecture and subclonal diversity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.